<HashMap><database>biostudies-arrayexpress</database><scores/><additional><submitter>Neil Morgan</submitter><organism>Mus musculus</organism><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-15572</full_dataset_link><description>To identify the mechanism through which SLFN14 may regulate megakaryopoiesis and platelet function, we performed RNA sequencing analysis to define alterations in gene activity arising as a result of conditionally knocking down Slfn14 in vivo. Bulk RNA-sequencing was performed on total RNA extracted from mature murine Slfn14fl/flPF4-Cre derived MKs and peripheral blood platelets and compared to Slfn14+/+PF4-Cre control MKs/platelets. All individual samples were run in triplicate and normalised before comparisons between each SLFN14 mutant.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Library Construction - Illumina/NEB kit protocol - Libraries were prepared using the NEBNext® Ultra™ II Directional RNA Library Prep Kit for Illumina with NEBNext® rRNA Depletion Kit v2 (Human/Mouse/Rat) according to the manufacturer’s protocol. During this process, the libraires were indexed using NEBNext® Multiplex Oligos for Illumina® (96 Unique Dual Index Primer Pairs) Set 4. The prepared libraries were quantified via a fluorometric method involving a Promega QuantiFluor dsDNA assay and qualified using electrophoretic separation on the Agilent TapeStation 4200.</sample_protocol><sample_protocol>Sample Collection - Mice were exsanguinated under terminal anesthesia by isoflurane/O2 (5%) gas. Blood was drawn from the inferior vena cava, using a 25-gauge needle, into 1:10 (volume-to-volume ratio) acid citrate dextrose anticoagulant.</sample_protocol><sample_protocol>Sequencing - Sequencing was performed using the Illumina HiSeq 4000.</sample_protocol><sample_protocol>Nucleic Acid Extraction - Platelets and megakaryocytes were isolated and RNA was extracted using the RNeasy mini kit (Qiagen) according to manufacturer’s instructions</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>Processed Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><data_protocol>Data Transformation - RNA sequencing performed on platelet and MK RNA in triplicate groups from individual mice (Slfn14fl/flPF4-Cre, Slfn14f+/+PF4-Cre) and normalised comparing mutant and WT groups</data_protocol><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><instrument_platform>Illumina HiSeq 4000</instrument_platform><study_type>RNA-seq of total RNA</study_type><species>Mus musculus</species><pubmed_authors>Neil Morgan</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA-seq shows genes enhanced in translation and transcription pathways in MKs and platelets from Slfn14fl/flPF4-Cre mouse model</name><description>To identify the mechanism through which SLFN14 may regulate megakaryopoiesis and platelet function, we performed RNA sequencing analysis to define alterations in gene activity arising as a result of conditionally knocking down Slfn14 in vivo. Bulk RNA-sequencing was performed on total RNA extracted from mature murine Slfn14fl/flPF4-Cre derived MKs and peripheral blood platelets and compared to Slfn14+/+PF4-Cre control MKs/platelets. All individual samples were run in triplicate and normalised before comparisons between each SLFN14 mutant.</description><dates><release>2025-09-29T00:00:00Z</release><modification>2026-05-28T10:15:20.661Z</modification><creation>2025-09-12T14:40:47.614Z</creation></dates><accession>E-MTAB-15572</accession><cross_references><ENA>ERP180028</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0009653</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003816</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>